Associate Director, Biostatistics Alexion Pharmaceuticals IncAssociate Director, BiostatisticsBoston, MAThis is what you will do: The Associate Director, Biostatistics has sufficient experience working as a statistician in the pharmaceutical industry to independently perform and lead statistical work within a project, an indication within a more complex project. Accountabilities for supporting projects directly include: Lead the statistical thinking and contributions to the delivery of studies, development plans, regulatory strategy, health technology assessment and/or commercial activities.
Senior Manager, Biostatistics Bristol-Myers Squibb CoSenior Manager, BiostatisticsCambridge, MA$188,730–$228,701 / yearBased on eligibility*, additional time off for employees may include unlimited paid sick time, up to 2 paid volunteer days per year, summer hours flexibility, leaves of absence for medical, personal, parental, caregiver, bereavement, and military needs and an annual Global Shutdown between Christmas and New Years Day. Each of us is empowered to apply our individual talents and unique perspectives in a supportive culture, promoting global participation in clinical trials, while our shared values of passion, innovation, urgency, accountability, inclusion and integrity bring out the highest potential of each of our colleagues.
NewAssociate Director, Biostatistics ReplimuneAssociate Director, BiostatisticsWoburn, MassachusettsThe RPx platform is designed to have a unique dual local and systemic activity consisting of direct selective virus-mediated killing of the tumor resulting in the release of tumor derived antigens and altering of the tumor microenvironment to ignite a strong and durable systemic response. For this role, the anticipated base pay range is $193,500-$250,500 The exact base pay offered for this role will depend on various factors, including but not limited to the selected candidate’s unique set of qualifications, skills, and experience.
Director Biostatistics Alnylam Pharmaceuticals IncDirector BiostatisticsCambridge, MACollaborates with Clinical Development, Regulatory and Clinical Operations Expertise Areas to design innovative clinical trials Authors the statistical sections of clinical trial protocols and statistical analysis plans Reviews and approves stratification/randomization schema Collaborates with Data Management, Clinical Development and Clinical Operations on design of eCRFs Provides statistical guidance on conduct of ongoing trials Collaborates with Statistical Programmers on summary and analysis of trial data. Leads biostatistics support for worldwide regulatory submissions Represents Alnylam in meetings with regulators, Key Opinion Leaders, partners, and other stakeholders Contributes to scientific articles, summarizing data collected in Alnylam trials Consults with Research, Preclinical, Clinical Pharmacology, Medical Affairs and Commercial colleagues on statistical questions in their work Responsible for timeline management across their clinical development program Ph.
Senior Director Biostatistics Head of Statistical Innovation & Methodology Alnylam Pharmaceuticals IncSenior Director Biostatistics Head of Statistical Innovation & MethodologyMAMentor statisticians, promote knowledge sharing, and, as the function grows, build and lead a statistical innovation and methodology team to strengthen methodological expertise and foster a culture of statistical innovation within the Biostatistics organization. Engage externally with scientific organizations, regulatory agencies, and academic collaborators to contribute to methodological advancement, inform industry best practices, and ensure awareness of emerging statistical approaches.
Senior Director Oncology Biostatistics Bristol-Myers Squibb CoSenior Director Oncology BiostatisticsMA$279,410–$338,582 / yearThe Senior Director provides expertise and guidance in collaboration with cross-functional groups broadly across the organization in establishing study design and analyses and strategy, and institutes best practices with regards to planning, execution, interpretation and regulatory submission of clinical projects and studies. Based on eligibility*, additional time off for employees may include unlimited paid sick time, up to 2 paid volunteer days per year, summer hours flexibility, leaves of absence for medical, personal, parental, caregiver, bereavement, and military needs and an annual Global Shutdown between Christmas and New Years Day.
Director/Sr Director Biostatistics Aura BioSearchDirector/Sr Director BiostatisticsBoston, MassachusettsIn this role, reporting to the Vice President of Biometrics, you will work with cross-functional clinical teams overseeing statistical activities across clinical programs, including managing statistical deliverables outsourced to CROs. Provide strategic input for trial designs in early-phase and late-phase studies.
NewSenior Manager, Biostatistics AlexionSenior Manager, BiostatisticsBoston, MassachusettsThe Senior Manager, Biostatistics has sufficient experience working as a statistician in the pharmaceutical industry to be working independently on activities relating to clinical trial design, delivery and interpretation, preclinical studies, regulatory submissions and/or commercialization. Accountable for the quality of their statistical work; provide discipline-specific understanding, insight and constructive challenge and take ownership of development needs, seek coaching or training opportunities.
VP, Head of Biometrics TScan TherapeuticsVP, Head of BiometricsWaltham, MA$340,000–$380,000 / yearAs a key member of the Senior Leadership Team, the VP, Biostatistics will partner closely with Clinical Development, Clinical Operations, Regulatory Affairs, Data Sciences, Translational Medicine and Executive Leadership to drive successful development and registration strategies. TScan is seeking an accomplished and strategic Vice President, Biostatistics to lead all biometric activities across the company's clinical development portfolio, including multiple ongoing and planned studies supporting the advancement of TCR-T cell therapies for patients with cancer.
Senior Manager/Associate Director, Biostatistics Beam Therapeutics IncSenior Manager/Associate Director, BiostatisticsCambridge, MA$155,000–$225,000 / yearThe ideal candidate will work closely with cross-functional study teams to provide statistical input, contribute to study-level strategy, and oversee CRO biometrics deliverables to support timely and high-quality trial execution. Beam's suite of gene editing technologies is anchored by base editing, a proprietary technology that is designed to enable precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the DNA.
Senior Manager, Biostatistics Alexion Pharmaceuticals IncSenior Manager, BiostatisticsBoston, MA$119,848–$157,300.50 / yearThis is what you will do: The Senior Manager, Biostatistics has sufficient experience working as a statistician in the pharmaceutical industry to be working independently on activities relating to clinical trial design, delivery and interpretation, preclinical studies, regulatory submissions and/or commercialization. You will be responsible for: Provide statistical expertise for complex design and interpretation for preclinical or clinical programmed, high level internal governance committees, regulatory submissions and/or commercialization.
Senior Director, Biostatistics Zenas BioPharmaSenior Director, BiostatisticsWaltham, MA$227,400–$284,256 / yearZenas' earlier stage programs include ZB021, a clinical-stage, potentially best-in-class, oral, IL-17AA/AF inhibitor; ZB022, a preclinical, potentially best-in-class, oral, brain-penetrant, TYK2 inhibitor; and ZB014, a preclinical half-life extended anti-CD-19 and FcRIIb monoclonal antibody. Key Responsibilities: Set biostatistical strategy for one or more clinical development programs, including clinical development plans, contribution to study trial design, analysis planning, study results presentation and interpretation, clinical study report authoring, regulatory submissions, and publications.
Senior Director, Biostatistics Zenas BioPharma (USA) LLCSenior Director, BiostatisticsWaltham, MA$227,400–$284,256 / yearZenas' earlier stage programs include ZB021, a clinical-stage, potentially best-in-class, oral, IL-17AA/AF inhibitor; ZB022, a preclinical, potentially best-in-class, oral, brain-penetrant, TYK2 inhibitor; and ZB014, a preclinical half-life extended anti-CD-19 and FcRIIb monoclonal antibody. Key Responsibilities: Set biostatistical strategy for one or more clinical development programs, including clinical development plans, contribution to study trial design, analysis planning, study results presentation and interpretation, clinical study report authoring, regulatory submissions, and publications.
Director/ Senior Director, Biostatistics Cogent BiosciencesDirector/ Senior Director, BiostatisticsWaltham, Massachusetts$225,000–$265,000 / yearYou will collaborate closely with partner functions—including Medical, Clinical Science, Clinical Operations, Data Management, and Statistical Programming—to support study objectives, contribute to regulatory submissions, and help drive the success of clinical development programs. Bezuclastinib has exhibited promising initial data across all three trials: APEX in AdvSM, SUMMIT in NonAdvSM and PEAK in GIST, including an encouraging safety profile across 600+ patients in single agent and combination dosing.
Senior Manager/Associate Director, Biostatistics Beam TherapeuticsSenior Manager/Associate Director, BiostatisticsCambridge, MA$155,000–$225,000 / yearThe ideal candidate will work closely with cross-functional study teams to provide statistical input, contribute to study-level strategy, and oversee CRO biometrics deliverables to support timely and high-quality trial execution. Beam’s suite of gene editing technologies is anchored by base editing, a proprietary technology that is designed to enable precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the DNA.
Director or Senior Director of Biostatistics Kymera TherapeuticsDirector or Senior Director of BiostatisticsWatertown, MA$195,000–$330,000 / yearHaving advanced the first degrader into the clinic for immunological diseases, Kymera is focused on building an industry-leading pipeline of oral small molecule degraders to provide a new generation of convenient, highly effective therapies for patients with these conditions. As the Lead Statistician, you will spearhead the statistical efforts of one or more clinical programs, playing a key role in the clinical development plan, regulatory submissions, and overall data strategy.
VP, Head of Biometrics TScan Therapeutics IncVP, Head of BiometricsWaltham, MA$340,000–$380,000 / yearAs a key member of the Senior Leadership Team, the VP, Biostatistics will partner closely with Clinical Development, Clinical Operations, Regulatory Affairs, Data Sciences, Translational Medicine and Executive Leadership to drive successful development and registration strategies. Position Summary: TScan is seeking an accomplished and strategic Vice President, Biostatistics to lead all biometric activities across the company's clinical development portfolio, including multiple ongoing and planned studies supporting the advancement of TCR-T cell therapies for patients with cancer.
Biostatistics Researcher PhaseVBiostatistics ResearcherCambridge, MAResearch : Support the development of research papers for statistical, machine learning, and medical journals on modern methodological approaches relevant to the company's interests and computing platform development, as well as applied papers growing out of consulting projects or conference interactions. PhaseV is a Boston-based technology company that redefines clinical development at scale with its enterprise-ready, multi-modal AI/ML platform — accelerating decisions, de-risking trials, and driving more efficient portfolio strategies.
NewSenior Statistician GenentechSenior StatisticianBoston, MassachusettsAs trusted analytical partners in end-to-end drug development, Biostatistics leverages data to drive scientifically rigorous programmatic decisions across Roche’s Development portfolio; Biostatistics designs robust trials and analysis plans that increase the probability of technical success, accelerating timelines to advance Roche’s clinical pipeline and promote regulatory success — ultimately bringing medicines to our patients faster. This role ensures the scientific rigor and regulatory compliance of the study by contributing to protocol development, authoring statistical analysis plans, performing or overseeing data analyses, and supporting the interpretation and communication of results.
Senior Principal Statistician GenentechSenior Principal StatisticianBoston, MassachusettsAs trusted analytical partners in end-to-end drug development, Biostatistics leverages data to drive scientifically rigorous programmatic decisions across Roche’s Development portfolio; Biostatistics designs robust trials and analysis plans that increase the probability of technical success, accelerating timelines to advance Roche’s clinical pipeline and promote regulatory success — ultimately bringing medicines to our patients faster. This role ensures the scientific rigor and regulatory compliance of the study by contributing to protocol development, authoring statistical analysis plans, performing or overseeing data analyses, and supporting the interpretation and communication of results.